azoxymethane has been researched along with piroxicam in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 10 (66.67) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aligia, C; Kelloff, G; Kulkarni, N; Reddy, BS; Tokumo, K | 1 |
| Kelloff, G; Maruyama, H; Reddy, BS | 1 |
| Holt, PR; Liu, T; Mokuolu, AO; Rao, CV; Reddy, BS | 1 |
| Bissonnette, M; Brasitus, TA; Earnest, D; Frawley, BP; Niedziela, SM; Roy, HK; Wali, RK | 1 |
| Chen, CD; Harris, C; Velasco, M; Wargovich, MJ; Yang, E | 1 |
| Allan, C; Brasitus, TA; Rigas, B; Tsioulias, GJ; Wali, RK | 1 |
| Kelloff, G; Kulkarni, N; Reddy, BS; Singh, J | 1 |
| Kelloff, G; Reddy, BS; Singh, J | 1 |
| Barnes, LH; Kelloff, GV; Lubet, RA; Pereira, MA; Steele, VE | 1 |
| Kawabata, K; Matsunaga, K; Mori, H; Morishita, Y; Sugie, S; Tanaka, T; Yoshimi, N | 1 |
| Kelloff, GJ; Kramer, PM; Li, H; Lubet, RA; Pereira, MA; Steele, VE | 1 |
| Kosmeder, JW; Mehta, RG; Murillo, G; Pezzuto, JM | 1 |
| Caderni, G; Dolara, P; Femia, AP | 1 |
| Reddy, BS | 1 |
| Gunning, WT; Lubet, R; Pereira, MA; Tao, LH; Wang, W | 1 |
1 review(s) available for azoxymethane and piroxicam
| Article | Year |
|---|---|
Studies with the azoxymethane-rat preclinical model for assessing colon tumor development and chemoprevention.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Azoxymethane; Chemoprevention; Colonic Neoplasms; Cyclooxygenase 2; Disease Models, Animal; Dose-Response Relationship, Drug; Eflornithine; Fatty Acids, Omega-3; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Isoenzymes; Membrane Proteins; Models, Biological; Piroxicam; Prostaglandin-Endoperoxide Synthases; Rats; Risk Assessment | 2004 |
14 other study(ies) available for azoxymethane and piroxicam
| Article | Year |
|---|---|
Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds.
Topics: Animals; Azoxymethane; Colonic Neoplasms; Glycyrrhetinic Acid; Ibuprofen; Ketoprofen; Male; Piroxicam; Random Allocation; Rats; Rats, Inbred F344 | 1992 |
Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Azoxymethane; Colonic Neoplasms; Diet; Ear Canal; Ear Neoplasms; Intestinal Neoplasms; Intestine, Small; Male; Piroxicam; Rats; Rats, Inbred F344 | 1987 |
Regional chemoprevention of carcinogen-induced tumors in rat colon.
Topics: Animals; Anticarcinogenic Agents; Azoxymethane; Colonic Neoplasms; Eflornithine; Ellagic Acid; Male; Piroxicam; Pyrazines; Rats; Rats, Inbred F344; Thiones; Thiophenes | 1995 |
Selective preservation of protein kinase C-zeta in the chemoprevention of azoxymethane-induced colonic tumors by piroxicam.
Topics: Administration, Oral; Animals; Azoxymethane; Cell Transformation, Neoplastic; Colonic Neoplasms; Enzyme Induction; Gene Expression Regulation, Neoplastic; Male; Neoplasm Proteins; Piroxicam; Protein Kinase C; Rats; Rats, Inbred F344; Signal Transduction | 1995 |
Inhibition of aberrant crypt growth by non-steroidal anti-inflammatory agents and differentiation agents in the rat colon.
Topics: Acetaminophen; Adenoma; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aspirin; Azoxymethane; Colonic Neoplasms; Drug Screening Assays, Antitumor; Fenretinide; Ibuprofen; Isotretinoin; Male; Piroxicam; Precancerous Conditions; Rats; Rats, Inbred F344 | 1995 |
The effect of bile acids and piroxicam on MHC antigen expression in rat colonocytes during colon cancer development.
Topics: Animals; Azoxymethane; Bile Acids and Salts; Cell Transformation, Neoplastic; Colon; Colonic Neoplasms; Histocompatibility Antigens; Male; Piroxicam; Rats; Rats, Inbred F344 | 1994 |
Modulation of azoxymethane-induced mutational activation of ras protooncogenes by chemopreventive agents in colon carcinogenesis.
Topics: Animals; Anticarcinogenic Agents; Azoxymethane; Base Sequence; Colon; Colonic Neoplasms; Eflornithine; Genes, ras; Intestinal Mucosa; Male; Molecular Sequence Data; Mutation; Piroxicam; Polymerase Chain Reaction; Rats; Rats, Inbred F344 | 1994 |
Intermediate biomarkers of colon cancer: modulation of expression of ras oncogene by chemopreventive agents during azoxymethane induced colon carcinogenesis.
Topics: Affinity Labels; Animals; Azoxymethane; Biomarkers, Tumor; Blotting, Western; Colonic Neoplasms; Eflornithine; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Guanosine Triphosphate; Male; Piroxicam; Proto-Oncogene Proteins p21(ras); Rats | 1993 |
Piroxicam-induced regression of azoxymethane-induced aberrant crypt foci and prevention of colon cancer in rats.
Topics: Adenocarcinoma; Adenoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Azoxymethane; Carcinogens; Colon; Colonic Neoplasms; Drug Screening Assays, Antitumor; Male; Piroxicam; Precancerous Conditions; Rats; Rats, Inbred F344 | 1996 |
Regressive effects of various chemopreventive agents on azoxymethane-induced aberrant crypt foci in the rat colon.
Topics: 4-Butyrolactone; Animals; Anticarcinogenic Agents; Azoxymethane; Body Weight; Carcinogens; Chemoprevention; Chlorogenic Acid; Colonic Neoplasms; Drug Administration Schedule; Male; Methyl Methanesulfonate; Piroxicam; Rats; Rats, Inbred F344; Retinoids | 1997 |
Termination of piroxicam treatment and the occurrence of azoxymethane-induced colon cancer in rats.
Topics: Adenocarcinoma; Adenoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Azoxymethane; Body Weight; Carcinogenicity Tests; Carcinogens; Cell Division; Colonic Neoplasms; Disease Progression; Drug Administration Schedule; Intestinal Mucosa; Male; Piroxicam; Precancerous Conditions; Rats; Rats, Inbred F344 | 1999 |
Deguelin suppresses the formation of carcinogen-induced aberrant crypt foci in the colon of CF-1 mice.
Topics: Animals; Anticarcinogenic Agents; Azoxymethane; beta-N-Acetylhexosaminidases; Colon; Colonic Neoplasms; Female; Intestinal Mucosa; Mice; Molecular Structure; Piroxicam; Precancerous Conditions; Rotenone | 2003 |
Mucin-depleted foci (MDF) in the colon of rats treated with azoxymethane (AOM) are useful biomarkers for colon carcinogenesis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Azoxymethane; Biomarkers, Tumor; Body Weight; Carcinogens; Cholic Acid; Colon; Colonic Neoplasms; Male; Mucins; Piroxicam; Precancerous Conditions; Rats; Rats, Inbred F344 | 2004 |
Chemoprevention: mouse colon and lung tumor bioassay and modulation of DNA methylation as a biomarker.
Topics: Animals; Azoxymethane; Biological Assay; Biomarkers; Budesonide; Carcinogens; Chemoprevention; Colonic Neoplasms; Dexamethasone; DNA Methylation; Dose-Response Relationship, Drug; Glucocorticoids; Insulin-Like Growth Factor II; Lung Neoplasms; Mice; Mice, Inbred Strains; Piroxicam; Urethane | 2005 |